• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过结构域交换工程改造的嵌合细菌素 S5-PmnH 可有效控制小鼠角膜炎和肺部模型中的铜绿假单胞菌感染。

Chimeric bacteriocin S5-PmnH engineered by domain swapping efficiently controls Pseudomonas aeruginosa infection in murine keratitis and lung models.

机构信息

Nomads UAB, Geležinio vilko 29A, 01112, Vilnius, Lithuania.

Institute of Biotechnology, Vilnius University, Saulėtekio al. 7, 10257, Vilnius, Lithuania.

出版信息

Sci Rep. 2022 Apr 19;12(1):5865. doi: 10.1038/s41598-022-09865-8.

DOI:10.1038/s41598-022-09865-8
PMID:35440606
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9018753/
Abstract

Rampant rise of multidrug resistant strains among Gram-negative bacteria has necessitated investigation of alternative antimicrobial agents with novel modes of action including antimicrobial proteins such as bacteriocins. The main hurdle in the clinical development of bacteriocin biologics is their narrow specificity and limited strain activity spectrum. Genome mining of bacteria for broadly active bacteriocins have identified a number of promising candidates but attempts to improve these natural multidomain proteins further, for example by combining domains of different origin, have so far met with limited success. We have found that domain swapping of Pseudomonas bacteriocins of porin type, when carried out between phylogenetically related molecules with similar mechanism of activity, allows the generation of highly active molecules with broader spectrum of activity, for example by abolishing strain resistance due to the presence of immunity proteins. The most broadly active chimera engineered in this study, S5-PmnH, exhibits excellent control of Pseudomonas aeruginosa infection in validated murine keratitis and lung infection models.

摘要

革兰氏阴性菌中耐药菌株的猖獗出现,促使人们研究具有新型作用模式的替代抗菌药物,包括抗菌蛋白,如细菌素。细菌素生物制剂在临床开发中的主要障碍是其狭窄的特异性和有限的菌株活性谱。对细菌进行广泛活性细菌素的基因组挖掘已经确定了许多有前途的候选者,但迄今为止,试图进一步改进这些天然多结构域蛋白,例如通过组合不同来源的结构域,取得的成功有限。我们发现,当在具有相似作用机制的系统发育上相关的分子之间进行肠孔型假单胞菌细菌素的结构域交换时,可以产生具有更广泛活性谱的高度活性分子,例如通过消除由于存在免疫蛋白而导致的菌株抗性。在这项研究中设计的最广泛活性嵌合体 S5-PmnH,在经过验证的小鼠角膜炎和肺部感染模型中,对铜绿假单胞菌感染具有出色的控制作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe6/9018753/56de415c02ff/41598_2022_9865_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe6/9018753/59108e19456e/41598_2022_9865_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe6/9018753/d974e290530b/41598_2022_9865_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe6/9018753/160b1562657d/41598_2022_9865_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe6/9018753/cc236cdf5d79/41598_2022_9865_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe6/9018753/81066be3787e/41598_2022_9865_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe6/9018753/02ef443bb79f/41598_2022_9865_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe6/9018753/56de415c02ff/41598_2022_9865_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe6/9018753/59108e19456e/41598_2022_9865_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe6/9018753/d974e290530b/41598_2022_9865_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe6/9018753/160b1562657d/41598_2022_9865_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe6/9018753/cc236cdf5d79/41598_2022_9865_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe6/9018753/81066be3787e/41598_2022_9865_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe6/9018753/02ef443bb79f/41598_2022_9865_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe6/9018753/56de415c02ff/41598_2022_9865_Fig7_HTML.jpg

相似文献

1
Chimeric bacteriocin S5-PmnH engineered by domain swapping efficiently controls Pseudomonas aeruginosa infection in murine keratitis and lung models.通过结构域交换工程改造的嵌合细菌素 S5-PmnH 可有效控制小鼠角膜炎和肺部模型中的铜绿假单胞菌感染。
Sci Rep. 2022 Apr 19;12(1):5865. doi: 10.1038/s41598-022-09865-8.
2
A Natural Chimeric Bacteriocin with Novel Pore-Forming Activity Parasitizes the Ferrichrome Transporter.一种具有新型成孔活性的天然嵌合细菌素寄生于铁载体转运蛋白。
mBio. 2017 Feb 21;8(1):e01961-16. doi: 10.1128/mBio.01961-16.
3
Efficacy of species-specific protein antibiotics in a murine model of acute Pseudomonas aeruginosa lung infection.种特异性蛋白质抗生素在小鼠急性铜绿假单胞菌肺部感染模型中的疗效。
Sci Rep. 2016 Jul 22;6:30201. doi: 10.1038/srep30201.
4
Pseudomonas aeruginosa Soluble Pyocins as Antibacterial Weapons.铜绿假单胞菌可溶性噬菌体作为抗菌武器。
Methods Mol Biol. 2024;2721:125-136. doi: 10.1007/978-1-0716-3473-8_9.
5
Characterization of the bacteriocins and the PrtR regulator in a plant-associated Pseudomonas strain.鉴定一株植物相关假单胞菌中的细菌素和 PrtR 调控因子。
J Biotechnol. 2020 Jan 10;307:182-192. doi: 10.1016/j.jbiotec.2019.11.003. Epub 2019 Nov 4.
6
Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections.广谱抗菌组合药物的开发用于治疗金黄色葡萄球菌和铜绿假单胞菌角膜感染。
Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.01929-18. Print 2019 Jan.
7
Therapeutic potential of the antimicrobial peptide OH-CATH30 for antibiotic-resistant Pseudomonas aeruginosa keratitis.抗菌肽OH-CATH30对耐抗生素铜绿假单胞菌性角膜炎的治疗潜力。
Antimicrob Agents Chemother. 2014 Jun;58(6):3144-50. doi: 10.1128/AAC.00095-14. Epub 2014 Mar 17.
8
Heterogenous Susceptibility to R-Pyocins in Populations of Pseudomonas aeruginosa Sourced from Cystic Fibrosis Lungs.异质性对来源于囊性纤维化肺的铜绿假单胞菌群体中 R- Pyocins 的敏感性。
mBio. 2021 May 4;12(3):e00458-21. doi: 10.1128/mBio.00458-21.
9
Bacteriocin-mediated competition in cystic fibrosis lung infections.囊性纤维化肺部感染中细菌素介导的竞争
Proc Biol Sci. 2015 Sep 7;282(1814). doi: 10.1098/rspb.2015.0972.
10
Attenuation of infection by INP0341, a salicylidene acylhydrazide, in a murine model of keratitis.INP0341,一种水杨酰腙类化合物,对小鼠角膜炎模型感染的抑制作用。
Virulence. 2020 Dec;11(1):795-804. doi: 10.1080/21505594.2020.1776979.

引用本文的文献

1
Inhalable nanoparticle-based delivery systems for the treatment of pulmonary infections: and barrier-overcoming strategies.用于治疗肺部感染的基于可吸入纳米颗粒的递送系统及克服屏障的策略。
Drug Deliv. 2025 Dec;32(1):2544683. doi: 10.1080/10717544.2025.2544683. Epub 2025 Aug 11.
2
Molecular and functional analysis of a putative pyocin S9, with endonuclease activity from P. chlororaphis subsp aurantiaca PB-St2.来自橙色假单胞菌亚种PB-St2的具有核酸内切酶活性的假定绿脓菌素S9的分子和功能分析。
Arch Microbiol. 2025 May 8;207(6):138. doi: 10.1007/s00203-025-04345-9.
3
Novel Genetically Engineered Probiotics for Targeted Elimination of in Intestinal Colonization.

本文引用的文献

1
Pyocin efficacy in a murine model of Pseudomonas aeruginosa sepsis.噬菌体治疗铜绿假单胞菌脓毒症的疗效评价。
J Antimicrob Chemother. 2021 Aug 12;76(9):2317-2324. doi: 10.1093/jac/dkab199.
2
: An Audacious Pathogen with an Adaptable Arsenal of Virulence Factors.一种具有适应性毒力因子武器库的大胆病原体。
Int J Mol Sci. 2021 Mar 18;22(6):3128. doi: 10.3390/ijms22063128.
3
Bacteriophage endolysins - extending their application to tissues and the bloodstream.噬菌体溶菌素 - 将其应用扩展到组织和血液中。
用于靶向消除肠道定植菌的新型基因工程益生菌。
Biomedicines. 2023 Sep 27;11(10):2645. doi: 10.3390/biomedicines11102645.
4
Recent advances in therapeutic targets identification and development of treatment strategies towards Pseudomonas aeruginosa infections.近年来,针对铜绿假单胞菌感染的治疗靶点的鉴定和治疗策略的发展取得了进展。
BMC Microbiol. 2023 Mar 30;23(1):86. doi: 10.1186/s12866-023-02832-x.
5
Identification of Three Campylobacter Lysins and Enhancement of Their Anti-Escherichia coli Efficacy Using Colicin-Based Translocation and Receptor-Binding Domain Fusion.三种弯曲杆菌溶素的鉴定以及利用基于大肠杆菌素的易位和受体结合域融合提高其抗大肠杆菌功效
Microbiol Spectr. 2023 Feb 7;11(2):e0451522. doi: 10.1128/spectrum.04515-22.
Curr Opin Biotechnol. 2021 Apr;68:51-59. doi: 10.1016/j.copbio.2020.09.012. Epub 2020 Oct 27.
4
Prevalence of bacteriocins and their co-association with virulence factors within Pseudomonas aeruginosa catheter isolates.绿脓假单胞菌导尿管分离株中产细菌素的流行情况及其与毒力因子的共同关联。
Int J Med Microbiol. 2020 Dec;310(8):151454. doi: 10.1016/j.ijmm.2020.151454. Epub 2020 Sep 29.
5
Engineering of Long-Circulating Peptidoglycan Hydrolases Enables Efficient Treatment of Systemic Staphylococcus aureus Infection.工程化长循环肽聚糖水解酶可有效治疗全身性金黄色葡萄球菌感染。
mBio. 2020 Sep 22;11(5):e01781-20. doi: 10.1128/mBio.01781-20.
6
Pyocin S5 Import into Pseudomonas aeruginosa Reveals a Generic Mode of Bacteriocin Transport.噬菌素 S5 导入铜绿假单胞菌揭示了细菌素运输的通用模式。
mBio. 2020 Mar 10;11(2):e03230-19. doi: 10.1128/mBio.03230-19.
7
Clinical Impact of Antibiotics for the Treatment of Biofilm Infections.抗生素治疗生物膜感染的临床影响
Front Microbiol. 2020 Jan 9;10:2894. doi: 10.3389/fmicb.2019.02894. eCollection 2019.
8
Epidemiology, Treatment, and Prevention of Nosocomial Bacterial Pneumonia.医院获得性细菌性肺炎的流行病学、治疗与预防
J Clin Med. 2020 Jan 19;9(1):275. doi: 10.3390/jcm9010275.
9
Broad and Efficient Control of Klebsiella Pathogens by Peptidoglycan-Degrading and Pore-Forming Bacteriocins Klebicins.肽聚糖降解和孔形成细菌素 Klebicins 对肺炎克雷伯菌病原体的广泛和有效控制。
Sci Rep. 2019 Oct 28;9(1):15422. doi: 10.1038/s41598-019-51969-1.
10
Lysocins: Bioengineered Antimicrobials That Deliver Lysins across the Outer Membrane of Gram-Negative Bacteria.溶菌素:经工程改造的抗菌药物,可将溶菌酶递送至革兰氏阴性菌的外膜。
Antimicrob Agents Chemother. 2019 May 24;63(6). doi: 10.1128/AAC.00342-19. Print 2019 Jun.